News | Page 2 | Weill Department of Medicine

Many Americans Lack Access to a Gastroenterologist

Almost 50 million Americans—disproportionately in rural areas—must drive 25 miles or more to access a gastroenterologist for diagnosis and treatment of issues involving the digestive system, according to a study from Weill Cornell Medicine researchers led by Dr. Arun Jesudian, Associate Professor of Clinical Medicine in the division of Gastroenterology & Hepatology. Dr. Jesuidan is a transplant hepatologist at NewYork-Presbyterian/Weill Cornell Medical Center. Dr. Arun JesudianThe findings... Read More

Heart Health Takes Center Stage

Just in time for Heart Month, we invite Weill Department of Medicine clinicians to share our new landing page with their patients,which makes it easier for patients to find practical information to need a heart-healthy life. That includes preventive care, the latest diagnostic and surgical technologies, clinical trials, and news about what’s happening at our medical school, affiliated hospitals and clinical practices.

In Memoriam: Dr. Charles "Chuck" Steinberg

The Weill Department of Medicine is saddened to announce the recent loss of Dr. Charles “Chuck” Steinberg. A native of New York City, Dr. Steinberg acquired his medical degree from Weill Cornell Medical College and completed his residency at NewYork-Presbyterian/Weill Cornell Medical Center. Known to all as Chuck, Dr. Steinberg’s compassion and dedication to medicine was quickly recognized. After serving as chief medical resident, Dr. Steinberg completed his fellowship in infectious diseases at... Read More

CDC Grant Funds Initiatives for Breast Cancer Patients

Weill Cornell Medicine has received a five-year, $2.3 million grant from the Centers for Disease Control and Prevention to improve equitable access to care, quality of life and survival outcomes for young people with all stages of breast cancer, thanks to a team of researchers lead by principal investigator Dr. Vered Stearns and co-principal investigator Dr. Tessa Cigler, both in the division of Hematology and Medical Oncology.The grant will enable Weill Cornell Medicine to enhance care... Read More

Pulmonary Holds First-Ever Summit On Advanced Lung Disease & Transplantation

The division of Pulmonary & Critical Care Medicine had a busy fall, including holding its first-ever 2024 Advanced Respiratory Disease and Lung Transplant Summit, presented in partnership with NewYork-Presbyterian/Columbia University Medical Center. Held on September 26, 2024, the day-long conference opened with welcoming remarks from Dr. Anna Podolanczuk and featured faculty from both NewYork-Presbyterian/Weill Cornell Medical Center and NewYork-Presbyterian/Columbia University Medical... Read More

Updated Hep B Vaccine More Effective for People with HIV

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn’t respond to prior vaccination, according to the results of an international study led by Dr. Kristen Marks, an associate professor of medicine and infectious diseases specialist in the division of Infectious Diseases in the Weill Department of Medicine.The study, reported Dec. 1 in JAMA, showed that hepatitis B vaccine with a... Read More

Dr. Madeline R. Sterling Releases Scientific Statement on American Heart Association’s Life’s Essential 8

Dr. Madeline R. Sterling, Associate Professor of Medicine in the division of General Internal Medicine and clinician at Weill Cornell Internal Medicine Associates (WCIMA), recently released a scientific statement affirming the efficacy of the American Heart Association’s (AHA) Life’s Essential 8. The statement stems from Dr. Sterling’s three-year, $400,000 grant from the AHA to rest and implement behavior health interventions among home health aides to improve their cardiovascular health and... Read More

Study Details Surprising Biological Mechanisms Underlying Severe COVID-19

Severe COVID-19 arises in part from the SARS-CoV-2 virus’s impact on mitochondria, tiny oxygen-burning power plants in cells, which can help trigger a cascade of organ- and immune system-damaging events, suggests a study by investigators at Weill Cornell Medicine, Johns Hopkins Medicine, Children’s Hospital of Philadelphia, and the University of Pittsburgh School of Medicine, along with other members of the COVID-19 International Research Team.Severe COVID-19 has been considered an inflammatory... Read More

What a Gut Fungus Reveals About Symbiosis and Allergy

A fungus discovered in the mouse stomach may hold a key to fungal evolution within the gastrointestinal tract, according to new research led by Weill Cornell Medicine investigators. The finding suggests that preclinical studies until now have overlooked a major influencer of mouse physiology.Scientists recently have come to appreciate the importance, for human health and disease, of microbes—often called “commensals”—that naturally dwell in the gut. Bacterial commensals, for example, are known... Read More

Tirzepatide Shows Powerful Diabetes-Prevention Effect in Three-Year Trial

Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with a placebo, according to the results of a new study led in part by co-author Dr. Louis Aronne, the Sanford I. Weill Professor of Metabolic Research and director of the Comprehensive Weight Control Center, part of the Division of Endocrinology, Diabetes, and Metabolism in the Weill Department of... Read More